Inhibitory effect of curcuminoids on MCF-7 cell proliferation and structure-activity relationships

Cancer Letters

Volumn 129, Issue 1, 1998, Pages 111-116

  Simon, A ^a   Allais, D P ^a   Duroux, J L ^a   Basly, J P ^a   Durand Fontanier, S ^a   Delage, C ^a  

^a UNIVERSITY OF LIMOGES   (France)

Author keywords

Cell cycle analysis; Curcuma; Curcumin; Curcuminoids; Cyclocurcumin; MCF 7 human breast tumor cells; Structure activity relationships

Indexed keywords

ANTINEOPLASTIC AGENT; CURCUMIN; CYCLOCURCUMIN; DEMETHOXYCURCUMIN; DIDEMETHOXYCURCUMIN; ESTRADIOL VALERATE PLUS NORGESTREL; PHENOL DERIVATIVE; PROPIDIUM IODIDE; UNCLASSIFIED DRUG;

ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOSTASIS; DRUG STRUCTURE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANTICARCINOGENIC AGENTS; BREAST NEOPLASMS; CELL CYCLE; CELL DIVISION; COUMARIC ACIDS; CURCUMIN; HUMANS; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

CURCUMA; CURCUMA LONGA; MINK CELL FOCUS-FORMING VIRUS;

EID: 0032479574     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(98)00092-5     Document Type: Article

References (30)

1. 4 formation in rat peritoneal polymorphonuclear neutrophils (PMNL). Planta Medica. 58:1992;226.
2. Azuine M.A., Bhide S.V. Chemopreventive effect of turmeric against stomach and skin tumors induced by chemical carcinogens in Swiss mice. Nutr. Cancer. 17(1):1992;77-83.
3. Chen Y.K., Duniec Z.M., Liu B., Hagmann W., Gao X., Shimoji K.-I., Marnett L.J., Johnson C.R., Honn K.V. Endogenous 12(S)-HETE production by tumor cells and its role in metastasis. Cancer Res. 54:1994;1574-1579.
4. Conney A.H., Lysz T., Ferrado T., Abidi T.F., Manchand P.S., Laskin J.D., Huang M.-T. Inhibitory effect of curcumin and some related dietary compounds on tumor promotion and arachidonic acid metabolism in mouse skin. Adv. Enzyme Regul. 31:1991;384-385.
5. Es-Saady D., Najid A., Simon A., Denizot Y., Chulia A.J., Delage C. Effects of ursolic acid and its analogues on soybean 15-lipoxygenase activity and the proliferation rate of a human gastric tumor cell line. Mediators Inflammation. 3:1994;181-184.
6. Es-Saady D., Simon A., Jayat-Vignoles C., Chulia A.J., Delage C. MCF-7 cell cycle arrested at G1 through ursolic acid, and increased reduction of tetrazolium salts. Anticancer Res. 16:1996;481-486.
7. Es-Saady D., Simon A., Ollier M., Maurizis J.C., Chulia A.J., Delage C. Inhibitory effect of ursolic acid on B16 proliferation through cell cycle arrest. Cancer Lett. 106:1996;193-197.
8. Flynn D.L., Rafferty M.F., Boctor A.M. Inhibition of 5-hydroxyeicosatetraenoic acid (5-HETE) formation in intact human neutrophils by naturally occurring diarylheptanoids: inhibitory activities of curcuminoids and yakuchinones. Leukotrienes Med. 22:1996;357-360.
9. Honn K.V., Dunn J.R. Nafazatrom (Bay g 6575) inhibition of tumor cell lipoxygenase activity and cellular proliferation. FEBS Lett. 139:1982;65-68.
10. Huang M.-T., Lysz T., Ferrado T., Abidi T.F., Laskin J.D., Conney A.H. Inhibitory effects of curcumin on in vitro lipoxygenase and cyclooxygenase activities in mouse epidermis. Cancer Res. 51:1991;813-819.
11. M.-T. Huang, F.M. Robertson, T. Lysz, T. Ferrado, Z.Y. Wang, C.A. Georgiadis, J.D. Laskin, A.H. Conney, Inhibitory effects of curcumin on carcinogenesis in mouse epidermis, in: M.-T. Huang, C.-T. Ho, C.Y. Lee (Eds.), Phenolic Compounds in Food and Their Effects on Health II: Antioxidants and Cancer Prevention, American Chemical Society, Washington, DC, 1992, pp. 339-349.
12. Huang M.-T., Wang Z.Y., Georgiadis C.A., Laskin J.D., Conney A.H. Inhibitory effects of curcumin on tumor initiation by benzo[a]pyrene and 7,12-dimethylbenz[a]anthracene. Carcinogenesis. 13(11):1992;2183-2186.
13. Kiuchi F., Iwakami S., Shibuya M., Hanaoka F., Sankawa U. Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids. Chem. Pharm. Bull. 40:1992;387-391.
14. Kiuchi F., Goto Y., Sigimoto N., Akao N., Kondo K., Tsuda Y. Nematocidal activity of turmeric: synergic action of curcuminoids. Chem. Pharm. Bull. 41:1993;1640-1643.
15. Kunchandy E., Rao M.N.A. Oxygen radical scavenging activity of curcumin. Int. J. Pharm. 58:1990;237-240.
16. Liu J.Y., Lin S.J., Lin J.K. Inhibitory effects of curcumin on protein kinase C activity induced by 12-O-tetradecanoyl-phorbol-13-acetate in NIH 3T3 cells. Carcinogenesis. 14:1993;857-861.
17. Mosman T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods. 65:1983;55-63.
18. Mukhopadhyay A., Basu N., Ghatak N., Gujral P.K. Anti-inflammatory and irritant activities of curcumin analogues in rats. Agents Actions. 12:1982;508-515.
19. Nagabhushan M., Amonkar A.J., Bhide S.V. In vitro antimutagenicity of curcumin against environmental mutagens. Food Chem. Toxicol. 25(7):1987;545-547.
20. Nagabhushan M., Bhide S.V. Curcumin as an inhibitor of cancer. J. Am. Coll. Nutr. 11:1992;192-198.
21. Najid A., Beneytout J.L., Tixier M. Cytotoxicity of arachidonic acid and of its lipoxygenase metabolite 15-hydroperoxyeicosatetraenoic acid, in human breast cancer MCF-7 cells in culture. Cancer Lett. 46:1989;137-141.
22. Najid A., Simon A., Cook J., Chable-Rabinovitch H., Delage C., Chulia A.J., Rigaud M. Characterization of ursolic acid as a lipoxygenase inhibitor using macrophages, platelets and differentiated HL-60 leukemic cells. FEBS Lett. 299:1992;213-217.
23. Rao T.S., Basu N., Siddiqui H.H. Anti-inflammatory activity of curcumin analogues. Indian J. Med. Res. 75:1982;574-578.
24. Satoskar R.R., Shah S.J., Shenoy S.G. Evaluation of anti-inflammatory property of curcumin (diferuloyl methane) in patients with postoperative inflammation. Int. J. Clin. Pharm. Ther. Toxicol. 24:1986;651-654.
25. Sharma O.P. Antioxidant activity of curcumin and related compounds. Biochem. Pharmacol. 25:1976;1811-1812.
26. Simon A., Najid A., Chulia A.J., Delage C., Rigaud M. Inhibition of lipoxygenase and HL-60 leukemic cell proliferation by ursolic acid isolated from heather flowers (Calluna vulgaris). Biochim. Biophys. Acta. 1125:1992;68-72.
27. Soudamini K.K., Kuttan R. Inhibition of chemical carcinogenesis by curcumin. J. Ethnopharmacol. 27:1989;227-233.
28. Srimal R., Dhawan B.N. Pharmacology of diferulylmethane (curcumin), a non-steroidal anti-inflammatory agent. J. Pharm. Pharmacol. 25:1973;447-452.
29. Toda S., Miyase T., Arichi H., Tanizawa H., Takino Y. Natural antioxidants. III. Antioxidative components isolated from rhizome of Curcuma longa L. Chem. Pharm. Bull. 33:1985;1725-1728.
30. Werner E.J., Waltenga R.W., Dubowy R.L., Boone S., Stuart M.J. Inhibition of malignant neuroblastoma cell DNA synthesis by lipoxygenase metabolites of arachidonic acid. Cancer Res. 45:1985;561-563.